Response to Comments: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules

This A59747 document is a response-to-comments notice regarding MolDX LCD L39682 (Molecular Testing for Risk Stratification of Thyroid Nodules) and does not itself set coverage criteria. Coverage rules and clinical criteria are contained in LCD L39682, which entered notice 6/13/2024 and is effective 7/28/2024.

"This document contains responses to public comments on MolDX LCD L39682 (Molecular Testing for Risk Stratification of Thyroid Nodules); coverage criteria are defined in LCD L39682 rather than in th..."

Sign up to see full coverage criteria, indications, and limitations.